SCHEMBL4722765

SCHEMBL4722765

CC(CNC(=O)OC(C)(C)C)N1CCN(c2ncccn2)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.46
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PCSK9 Q8NBP7 1/20 0.42
MAPT P10636 1/20 0.42
DRD2 P14416 5/20 0.42
ACHE P22303 1/20 0.41
HTR1A P08908 1/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
UTS2R Q9UKP6 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4724692 0.86 ACHE (0.43) PCSK9MAPTDRD2ACHEUTS2R
SCHEMBL4766157 0.82 HRH3 (0.45) ALDH1A1PCSK9DRD2UTS2RHPGD
SCHEMBL4765791 0.78 UTS2R (0.41) PCSK9DRD2UTS2R
SCHEMBL27566114 0.78 CTSL (0.42) KDM4EALDH1A1TDP1PCSK9DRD2
SCHEMBL4519114 0.78 CTSL (0.42) KDM4EALDH1A1TDP1PCSK9DRD2
SCHEMBL8173021 0.77 PCSK9 (0.38) ALDH1A1TDP1PCSK9DRD2MEN1
SCHEMBL29357542 0.76 NCF1 (0.51) KDM4EMAPTDRD2MEN1KMT2A
SCHEMBL22455152 0.76 NCF1 (0.51) KDM4EMAPTDRD2MEN1KMT2A
SCHEMBL4498858 0.76 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL15383665 0.76 KDM4E (0.61) GPR119KDM4EALDH1A1MAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917262-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2008-05-07 EP disclosed
WO-2007020194-A1 PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-02-22 WO disclosed